|
|
 |
|
Viewing report
|
|
|
|
IT Software Tools for Life Science and Drug Discovery R&D
Fuji-Keizai USA, Inc., June 2009, Pages: 158
IT Software Tools for Life Science and Drug Discovery R&D: Bioscience, Biotechnology, Pharmaceutical Company and Institute’s IT Software Tools, Strategy, and WW Market Outlook
This report examines the growing worldwide IT software and services market for the life science and drug discovery R&D community. The broad and high-level study takes a business focus and analyzes this interesting vertical market that supports key biomedical advancements.
The emergence of big-budget, life science and drug discovery R&D initiatives sponsored by world governments and other players, combined with the rapid deployments of many types of new analytical instruments has created an incredible set of drug discovery opportunities and challenges for academic labs, R&D institutes and drug making companies alike. Their enormous data output is driving the need to acquire key IT software tools and service solutions even in a major recession.
Big pharma and biotech companies continue to suffer from high R&D costs, drug patent expirations, lower new drug product output, more competition, regulatory challenges and other issues. A growing number of drug makers have turned to reorganizing their business models and are using powerful computer infrastructure and IT software solutions that will help transform their companies with next generation R&D capabilities. They hope to shorten their drug R&D timelines and reduce costs.
The study analyzes the market for IT software tools and services that enable life science and drug R&D. The report segments the software tools and services market by key R&D technology areas that map to drug R&D functions. The R&D tools, such as DNA arrays, next-generation sequencing, cell analysis, biomarkers, knowledge management, ELNs, LIMS and others are discussed.
This report discusses the interesting IT software topics with key findings. The study estimates that the worldwide IT software and services market for life science and drug R&D will reach $1.8 billion in 2009, with a strong growth rate. The research report is for marketers, business development, top executives, investors, VCs, consultants, R&D managers, or entrepreneurs. The report discusses a number of interesting customer case studies and includes 21 company profiles. This report uses 41 figures and tables to illustrate the findings. The study features many convenient tables that help the reader scan the details of key trends, market segmentation, revenue outlook, products, key customers and the like.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
IT Software Tools for Life Science and Drug Discovery R&D
Electronic Laboratory Notebooks (ELNs) - Global Strategic Business Report
Back to the Lab! Improving R&D Productivity and Efficiency with LIMS and ELNs
Biomarkers - Advanced Technologies and Global Market (2009-2014)
Nanobiotechnology Applications, Markets and Companies
European Markets for Laboratory Information Management Systems
U.S. Laboratory Information Management System (LIMS) Markets
Medical Nanotechnology Markets
How IT Helps Solve Pharma's R&D Problems: In Silico Drug Discovery
European Markets for Grid Computing in Life Sciences R&D
|
|
|
|
